Insights, news and articles from the frontline of Pharma

All Articles White Papers Latest News

August 18 2022

Is DiGA the way forward? – What does the optimal reimbursement model look like?

3 min read

August 18 2022

Women’s health is greater than Femtech – and the opportunity is huge. 

4 min read

August 18 2022

AI-Powered Drug Discovery – buzzword or the future?

3 min read

August 9 2022

Gene Therapies: Can the industry keep up its momentum or will it burn out?

5 min read

August 9 2022

The cutting edge of biotech: the continuous drive to achieve next-gen greatness

5 min read

August 9 2022

Access for one, access for all: if no longer rare, how will biotech ensure sustainable access to CGTs to the masses?

6 min read

July 18 2022

Throw it against the wall and see what sticks; Players testing their ‘new’ molecular entities in numerous immuno-oncology or autoimmune settings concurrently

3 min read

July 18 2022

Assembling all the bits and pieces – tackling capacity constraints for the successful rollout for neurological therapies

3 min read

July 18 2022

Venturing Into the Unknown: How Pharma is Embracing Neuroscience R&D After Decades of Failure

3 min read

Contact information

Fill in the contact form and a member of your team will get back to you

  • +44 (0) 203 929 0534
  • Eradigm Consulting Fora,
    180 Borough High Street,
    London, SE1 1LB
p